ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯¹æ¾Ï¹×¿©¼º¾ÏŬ¸®´Ð
-
[SCI]
The relationship between twin births and maternal risk of breast cancer: A meta-analysis
Hye Sook Kim, Ok Hee Woo, Kyong Hwa Park, Sang Uk Woo, Dae Sik Yang, Ae-Ree Kim, Eun Sook Lee, Jae-Bok Lee, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo
/ The relationship between twin births and maternal risk of breast cancer: A meta-analysis
/ 131(2):671-677
/ 201201
-
[SCI]
The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer
In Keun Choi, Hwa Jung Sung, Ju-Han Lee, Jun Suk Kim, Jae Hong Seo
/ The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer
/ 70(4):555-558
/ 201201
-
[SCI]
Association of a vascular endothelial growth factor (VEGF) gene 936 C/T polymorphism with breast cancer risk: a meta-analysis
Dae Sik Yang, Ok Hee Woo, Kyong Hwa Park, Sang Uk Woo, Ae-Ree Kim, Eun Sook Lee, Jae-Bok Lee, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo
/ Association of a vascular endothelial growth factor (VEGF) gene 936 C/T polymorphism with breast cancer risk: a meta-analysis
/ 125(3):849-853
/ 201101
-
[SCI]
A phase II study of vinorelbine monotherapy in anthracycline and taxane pretreated metastatic breast cancer
Hee Yeon Seo, Hyun Joo Lee, Ok Hee Woo, Kyong Hwa Park, Sang Uk Woo, Dae Sik Yang, Ae-Ree Kim, Jae-Bok Lee, Eun Sook Lee, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo
/ A phase II study of vinorelbine monotherapy in anthracycline and taxane pretreated metastatic breast cancer
/ 29(2):360-365
/ 201101
-
[SCI]
Bevacizumab for salvage treatment of metastatic breast cancer: A systemic review and meta-analysis of randomized controlled trials
Jae-Bok Lee, Ok Hee Woo, Kyong Hwa Park, Sang Uk Woo, Dae Sik Yang, Ae-Ree Kim, Eun Sook Lee, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo
/ Bevacizumab for salvage treatment of metastatic breast cancer: A systemic review and meta-analysis of randomized controlled trials
/ 29(1):182-188
/ 201101